Response to: 'The time has come to revisit alternative interpretations of data underlying the EULAR management recommendations for rheumatoid arthritis' by Pirilä et al

Josef S Smolen¹, Robert B M Landewé², Désirée van der Heijde^{3

4}

Affiliations

¹ Division of Rheumatology, Department of Medicine, Medical University of Vienna, Vienna, Austria.
² Rheumatology, Atrium Medical Center Heerlen, Heerlen, The Netherlands.
³ Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
⁴ Rheumatology, Diakonhjemmet Hospital, Oslo, Norway.

PMID: 28450310
DOI: 10.1136/annrheumdis-2017-211524

Comment

Response to: 'The time has come to revisit alternative interpretations of data underlying the EULAR management recommendations for rheumatoid arthritis' by Pirilä et al

Josef S Smolen et al. Ann Rheum Dis. 2017 Dec.

. 2017 Dec;76(12):e50.

doi: 10.1136/annrheumdis-2017-211524. Epub 2017 Apr 27.

Authors

Josef S Smolen¹, Robert B M Landewé², Désirée van der Heijde^{3

4}

Affiliations

¹ Division of Rheumatology, Department of Medicine, Medical University of Vienna, Vienna, Austria.
² Rheumatology, Atrium Medical Center Heerlen, Heerlen, The Netherlands.
³ Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
⁴ Rheumatology, Diakonhjemmet Hospital, Oslo, Norway.

PMID: 28450310
DOI: 10.1136/annrheumdis-2017-211524

No abstract available

Keywords: DMARDs (synthetic); Rheumatoid Arthritis; Treatment.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Comment on

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update.
Smolen JS, Landewé R, Bijlsma J, Burmester G, Chatzidionysiou K, Dougados M, Nam J, Ramiro S, Voshaar M, van Vollenhoven R, Aletaha D, Aringer M, Boers M, Buckley CD, Buttgereit F, Bykerk V, Cardiel M, Combe B, Cutolo M, van Eijk-Hustings Y, Emery P, Finckh A, Gabay C, Gomez-Reino J, Gossec L, Gottenberg JE, Hazes JMW, Huizinga T, Jani M, Karateev D, Kouloumas M, Kvien T, Li Z, Mariette X, McInnes I, Mysler E, Nash P, Pavelka K, Poór G, Richez C, van Riel P, Rubbert-Roth A, Saag K, da Silva J, Stamm T, Takeuchi T, Westhovens R, de Wit M, van der Heijde D. Smolen JS, et al. Ann Rheum Dis. 2017 Jun;76(6):960-977. doi: 10.1136/annrheumdis-2016-210715. Epub 2017 Mar 6. Ann Rheum Dis. 2017. PMID: 28264816 Review.
Alternative interpretation of data for recommendations on how to manage rheumatoid arthritis.
Pirilä L, Sokka T, Kauppi MJ, Rantalaiho VM, Mervaala E, Puolakka K. Pirilä L, et al. Ann Rheum Dis. 2017 Dec;76(12):e49. doi: 10.1136/annrheumdis-2017-211505. Epub 2017 Apr 27. Ann Rheum Dis. 2017. PMID: 28450311 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Response to: 'The time has come to revisit alternative interpretations of data underlying the EULAR management recommendations for rheumatoid arthritis' by Pirilä et al

Affiliations

Response to: 'The time has come to revisit alternative interpretations of data underlying the EULAR management recommendations for rheumatoid arthritis' by Pirilä et al

Authors

Affiliations

Conflict of interest statement

Comment on

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical